168 related articles for article (PubMed ID: 28717429)
1. Circulating concentrations of interleukin (IL)-17 in patients with multiple sclerosis: Evaluation of the effects of gender, treatment, disease patterns and IL-23 receptor gene polymorphisms.
Ghaffari SA; Nemati M; Hajghani H; Ebrahimi H; Sheikhi A; Jafarzadeh A
Iran J Neurol; 2017 Jan; 16(1):15-25. PubMed ID: 28717429
[No Abstract] [Full Text] [Related]
2. Interleukins (IL-23 and IL-27) serum levels: Relationships with gene polymorphisms and disease patterns in multiple sclerosis patients under treatment with interferon and glatiramer acetate.
Barac IS; Văcăraș V; Iancu M; Mureșanu DF; Procopciuc LM
Heliyon; 2023 Jun; 9(6):e17427. PubMed ID: 37484355
[TBL] [Abstract][Full Text] [Related]
3. Increased Concentrations of Interleukin-33 in the Serum and Cerebrospinal Fluid of Patients with Multiple Sclerosis.
Jafarzadeh A; Mahdavi R; Jamali M; Hajghani H; Nemati M; Ebrahimi HA
Oman Med J; 2016 Jan; 31(1):40-5. PubMed ID: 26813806
[TBL] [Abstract][Full Text] [Related]
4. Higher circulating levels of chemokine CCL20 in patients with multiple sclerosis: evaluation of the influences of chemokine gene polymorphism, gender, treatment and disease pattern.
Jafarzadeh A; Bagherzadeh S; Ebrahimi HA; Hajghani H; Bazrafshani MR; Khosravimashizi A; Nemati M; Gadari F; Sabahi A; Iranmanesh F; Mohammadi MM; Daneshvar H
J Mol Neurosci; 2014 Jul; 53(3):500-5. PubMed ID: 24395091
[TBL] [Abstract][Full Text] [Related]
5. Lower serum levels of Th2-related chemokine CCL22 in women patients with multiple sclerosis: a comparison between patients and healthy women.
Jafarzadeh A; Ebrahimi HA; Bagherzadeh S; Zarkesh F; Iranmanesh F; Najafzadeh A; Khosravimashizi A; Nemati M; Sabahi A; Hajghani H; Daneshvar H; Mohammadi MM
Inflammation; 2014 Apr; 37(2):604-10. PubMed ID: 24254331
[TBL] [Abstract][Full Text] [Related]
6. Potential Contribution of IL-27 and IL-23 Gene Polymorphisms to Multiple Sclerosis Susceptibility: An Association Analysis at Genotype and Haplotype Level.
Barac IS; Iancu M; Văcăraș V; Cozma A; Negrean V; Sâmpelean D; Mureșanu DF; Procopciuc LM
J Clin Med; 2021 Dec; 11(1):. PubMed ID: 35011777
[TBL] [Abstract][Full Text] [Related]
7. Mitoxantrone: a review of its use in multiple sclerosis.
Scott LJ; Figgitt DP
CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
[TBL] [Abstract][Full Text] [Related]
8. No Association between Single-Nucleotide Polymorphisms of The
Moheghi N; Sasannezhad P; John Walley A
Cell J; 2024 Mar; 26(3):185-193. PubMed ID: 38628091
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-17FT7488 allele is associated with a decreased risk of colorectal cancer and tumor progression.
Nemati K; Golmoghaddam H; Hosseini SV; Ghaderi A; Doroudchi M
Gene; 2015 Apr; 561(1):88-94. PubMed ID: 25680555
[TBL] [Abstract][Full Text] [Related]
10. Differential Frequency of CD8+ T Cell Subsets in Multiple Sclerosis Patients with Various Clinical Patterns.
Salehi Z; Doosti R; Beheshti M; Janzamin E; Sahraian MA; Izad M
PLoS One; 2016; 11(7):e0159565. PubMed ID: 27467597
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis.
Obradović D; Kataranovski M; Dincić E; Obradović S; Colić M
Vojnosanit Pregl; 2012 Feb; 69(2):151-6. PubMed ID: 22500369
[TBL] [Abstract][Full Text] [Related]
12. Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis.
Malhotra S; Fissolo N; Tintoré M; Wing AC; Castilló J; Vidal-Jordana A; Montalban X; Comabella M
J Neuroinflammation; 2015 Mar; 12():48. PubMed ID: 25879961
[TBL] [Abstract][Full Text] [Related]
13. Assessment of CCL27 and IL-11 in Multiple Sclerosis Patients Treated with Interferon-β and Glatiramer Acetate.
Ebrahimi Monfared M; Shapoori S; Mosayebi G; Khansarinejad B; Ghazavi A; Rezagholizamenjany M; Ganji A
Neuroimmunomodulation; 2019; 26(6):301-306. PubMed ID: 31935737
[TBL] [Abstract][Full Text] [Related]
14. IL23R gene polymorphism with juvenile idiopathic arthritis and its association with serum IL-17A.
Emami S; Ziaee V; Rezaei A; Sadr M; Maddah M; Amirzargar AA; Rezaei N
Int J Rheum Dis; 2016 Nov; 19(11):1189-1196. PubMed ID: 26016922
[TBL] [Abstract][Full Text] [Related]
15. Profiling of Canonical and Non-Traditional Cytokine Levels in Interferon-β-Treated Relapsing-Remitting-Multiple Sclerosis Patients.
D'Angelo C; Reale M; Costantini E; Di Nicola M; Porfilio I; de Andrés C; Fernández-Paredes L; Sánchez-Ramón S; Pasquali L
Front Immunol; 2018; 9():1240. PubMed ID: 29915590
[TBL] [Abstract][Full Text] [Related]
16. IL12B gene polymorphisms have sex-specific effects in relapsing-remitting multiple sclerosis.
Miteva L; Trenova A; Slavov G; Stanilova S
Acta Neurol Belg; 2019 Mar; 119(1):83-93. PubMed ID: 30554348
[TBL] [Abstract][Full Text] [Related]
17. The role of endogenous antiradical protective system in multiple sclerosis.
Davitashvili D; Beridze M; Shakarishvili R; Kiziria M; Sanikidze T
Georgian Med News; 2012 Apr; (205):11-9. PubMed ID: 22665726
[TBL] [Abstract][Full Text] [Related]
18. Cytokine Profile in Patients with Progressive Multiple Sclerosis and Its Association with Disease Progression and Disability.
Kallaur AP; Oliveira SR; Simão ANC; Alfieri DF; Flauzino T; Lopes J; de Carvalho Jennings Pereira WL; de Meleck Proença C; Borelli SD; Kaimen-Maciel DR; Maes M; Reiche EMV
Mol Neurobiol; 2017 May; 54(4):2950-2960. PubMed ID: 27023227
[TBL] [Abstract][Full Text] [Related]
19. Adhesion molecules in multiple sclerosis: relation to subtypes of disease and methylprednisolone therapy.
Elovaara I; Ukkonen M; Leppäkynnäs M; Lehtimäki T; Luomala M; Peltola J; Dastidar P
Arch Neurol; 2000 Apr; 57(4):546-51. PubMed ID: 10768630
[TBL] [Abstract][Full Text] [Related]
20. Genetic differences between primary progressive and relapsing-remitting multiple sclerosis: The impact of immune-related genes variability.
Kiselev I; Bashinskaya V; Baulina N; Kozin M; Popova E; Boyko A; Favorova O; Kulakova O
Mult Scler Relat Disord; 2019 Apr; 29():130-136. PubMed ID: 30711878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
